Johns Hopkins Pathology Homepage Dictionary For Patients For Physicians Giving
GALLBLADDER AND BILE DUCT CANCER
Understanding Gallbladder and Bile Duct Cancer Gallbladder and Bile Duct Cancer at Johns Hopkins What's New with Gallbladder and Bile Duct Cancer? Personal Stories Coping with Gallbladder and Bile Duct Cancer Resources for Gallbladder and Bile Duct Cancer


News Archive  

September 2009
Shell Ridge Summit walk for Bile Duct Cancer Research

May 2008
Genetic Analysis of Gallbladder Cancer Reveals Novel Biomarkers

June 2007
•Hopkins Fellow Wins International Award for Biliary Cancer Research

March 2005
•Potential New Target for Therapy in Biliary Cancer Discovered at Johns Hopkins

October 2004
•New Diagnostic Marker of Biliary Tract Carcinoma Discovered at Hopkins

April 2004
•Progression of Gene Hypermethylation in Gallstone Disease Leading to Gallbladder Cancer

October 2003
•New Pathway for Cancer Discovered in Hedgehog

July 2003
• Opportunity for Collaboration from New Biliary Cancer Laboratory

• NEW: Johns Hopkins Biliary Cancer Tissue Resources

February 2003
• Identification of novel tumor markers in biliary carcinomas using tissue microarrays

• Identification of novel targets of biliary tract cancers using global gene expression technology

• Telomere length variation in biliary tract metaplasia, dysplasia and carcinoma

September 2002
New Lab for Biliary Tract Cancers

February 2002
Creation of Tissue Microarrays

January 2002
• Immunohistochemical Analysis of Cyclooxygenase Enzymes in the Sequential Pathogenesis of Gallbladder Carcinoma

• Microsatellite Instability in Intraductal Papillary Mucinous Neoplasms of the Biliary Tree

• Genetic Analysis of Gallbladder Carcinoma and Precursor Lesions

July 2001
Molecular and Immunohistochemical Analysis

May 2001
A Novel Target for Anti-Biliary Tract Cancer Drug Development

March 2001
Differing Rates of Loss of Dpc4 Expression and of P53 Overexpression...



What's New?

November 2009

In a recent study, Dr. Chanjuan Shi at Hopkins used a novel ultrasensitive genetic technology (LigAmp) to detect mutations in the KRAS2 gene in bile and serum samples of patients with biliary tract cancer. This methodology holds promise for detecting biliary tract carcinoma at its early stages, where it can be cured by surgical resection, unlike the current situation where most patients present with advanced tumors.

PDF here

Reference: Journal of Molecular Diagnostics 2009;11: 583-9.



  
   
Copyright © 2000-2010 The Johns Hopkins University Feedback | Disclaimer